Active ingredientDirithromycinCat. No. P-D150-001CAS 62013-04-1Family · Pharmaceutical analytical standards
Dirithromycin
An oral macrolide antibiotic, chemically related to erythromycin, approved in the United States in 1995 for the treatment of bacterial infections. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a more fat-soluble prodrug: in the body it hydrolyses spontaneously, without the need for enzymes, into erythromycylamine, the active form; an enteric coating protects it from stomach acid.
Go to the active ingredient →Active ingredientDirithromycinCat. No. P-D150-001CAS 62013-04-1
Pharmacopoeial impurityDirithromycin EP Impurity ACat. No. P-D150-002CAS 26116-56-3
Pharmacopoeial impurityDirithromycin EP Impurity BCat. No. P-D150-003CAS 869485-36-9
Pharmacopoeial impurityDirithromycin EP Impurity DCat. No. P-D150-004
Pharmacopoeial impurityDirithromycin EP Impurity ECat. No. P-D150-005
Isotopically labelledDirithromycin-13C-d3Cat. No. P-D150-006
ImpurityDirithromycin N-OxideCat. No. P-D150-008CAS 910787-02-9No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceDirithromycin CRSEDQM code D2880000Family DirithromycinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.